Preclinical Neuro / Dermal

Melanotan-2

Synthetic α-MSH analogue (non-selective melanocortin agonist)

Melanocortin analogue linked to melanogenesis; not approved.

Back to technical sheets
Class
Synthetic α-MSH analogue (non-selective melanocortin agonist)
Also known as
Not approved; illicitly marketed

Mechanism of action

Non-selective melanocortin receptor agonist that stimulates melanogenesis (pigmentation) and has effects on sexual desire.

Evidence

Preclinical

Not approved. Sold illicitly and associated with adverse effects and changes in moles/melanocytes. Preclinical with safety not established.

Studied uses

  • None approved

Safety considerations

  • Safety concerns (mole changes, melanocytic risk)
  • Nausea, flushing, cardiovascular effects
  • Unregulated product of uncertain quality

Batch quality data

We publish these figures because they are the ones the program itself teaches you to ask for.

Presentation
Polvo liofilizado en vial sellado
10 mg Coming soon

Educational reference sheet. It is not a recommendation to use, a clinical indication or a protocol. Many of these compounds are marketed for research use only and are not approved for human use. Always cross-check with the primary literature and the regulation in your country.